Wei L - Search Results

1

A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin.

Wei L, Zhang M, Xu M, Chuang WL, Lu W, Xie W, Jia Z, Gong G, Li Y, Bae SH, Yang YF, Xie Q, Lin S, Chen X, Niu J, Jia J, Garimella T, Torbeyns A, McPhee F, Treitel M, Yin PD, Mo L. Wei L, et al. J Gastroenterol Hepatol. 2016 Nov;31(11):1860-1867. doi: 10.1111/jgh.13379. J Gastroenterol Hepatol. 2016. PMID: 27003037 Clinical Trial.

2

[Relationship between chronic hepatitis C and type II diabetes mellitus].

Yang SQ, Chen HS, Jiang D, Wei L, Ji LN, Wang Y. Yang SQ, et al. Among authors: wei l. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003 Mar;17(1):46-9. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003. PMID: 12870018 Chinese.

3

Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area.

Fan CL, Wei L, Jiang D, Chen HS, Gao Y, Li RB, Wang Y. Fan CL, et al. Among authors: wei l. World J Gastroenterol. 2003 Sep;9(9):2012-6. doi: 10.3748/wjg.v9.i9.2012. World J Gastroenterol. 2003. PMID: 12970896 Free PMC article.

4

[Evaluation of health-related quality of life in chronic hepatitis C women patients].

Guo F, Zhang L, Sun DG, Wang QX, Ji Y, Wang H, Sun Y, Wei L. Guo F, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2004 Mar;12(3):156-9. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15059300 Chinese.

5

[Hepatitis c virus genotype research by ABC programs of 5'-NCR restriction endonuclease digestion].

Qiu GH, Du SC, Sun NX, You P, Fan XF, Zhang YX, Wei L. Qiu GH, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2004 Apr;12(4):237-9. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15099479 Chinese.

6

[Hepatitis C recurrence after liver transplantation].

Guo F, Wei L. Guo F, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):382-4. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15225448 Review. Chinese. No abstract available.

7

[Using RNA interference to treat hepatitis virus: hope for future development].

Wei L. Wei L. Zhonghua Gan Zang Bing Za Zhi. 2004 Sep;12(9):555. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15387911 Chinese. No abstract available.

8

In vitro resistance to interferon of hepatitis B virus with precore mutation.

Wang Y, Wei L, Jiang D, Cong X, Fei R, Xiao J, Wang Y. Wang Y, et al. Among authors: wei l. World J Gastroenterol. 2005 Feb 7;11(5):649-55. doi: 10.3748/wjg.v11.i5.649. World J Gastroenterol. 2005. PMID: 15655815 Free PMC article.

9

Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up.

Fan W, Zhu W, Wei L, Wang Q, Yin L, Du S, Zhuang H. Fan W, et al. Among authors: wei l. J Gastroenterol. 2005 Jan;40(1):43-51. doi: 10.1007/s00535-004-1446-2. J Gastroenterol. 2005. PMID: 15692788

10

[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].

Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ. Zhao H, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):323-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732903 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,174 results

Search Page

Filters